Tagged Articles

Bayer 246 articles

Women who claim they were injured by Essure fighting for their day in court

Essure

Becky Beesley struggles not to cry when she thinks back on the day in 2012 that she decided to get the Essure permanent birth control. “Immediately my body rejected the procedure,” she told ABC 15 News. “My leg started to tremor and I threw up a couple of times.” Within a few months, serious health issues began to emerge. “I felt like there were little gremlins…that were just trying to claw their way out.” She says the pain became so excruciating, she had to quit her teaching job. Her doctor finally removed the implant, but the pain persisted. Beesley saw ... Read More

First four lawsuits set the stage for Xarelto bleeding events litigation

xarelto

Joseph Boudreaux was prescribed the blood thinner Xarelto, but a month later he began bleeding internally so badly that he was hospitalized and required several blood transfusions. Joseph Orr’s wife used Xarelto for about a month before she died from a brain hemorrhage. Dora Mingo took Xarelto after developing blood clots, but had to discontinue treatment after she began bleeding in her gastrointestinal tract. William Henry died from a gastrointestinal bleed after taking Xarelto to prevent strokes associated with his heart condition, atrial fibrillation. These are the first four cases set to go to trial among more than 7,200 in a ... Read More

Federal judge selects two Xarelto cases to serve as bellwethers

xarelto

U.S. District Judge Eldon Fallon has selected two lawsuits to serve as the first bellwether trials among more than 7,200 cases involving bleeding risks with the blockbuster blood thinner Xarelto. The lawsuits, filed against Johnson & Johnson, Janssen Pharmaceuticals, Bayer, and their related companies, claim the companies failed to warn about the severity of Xarelto bleeding risks and that there is no antidote on the market to reverse the bleeding effects of the drug in the event of a bleeding emergency. The first trial, scheduled for February 2017, involves the case of a Louisiana man who claims to have developed ... Read More

Merck to stop promoting Zontivity blood thinner in U.S.

blood cells

Merck & Co. will discontinue marketing in the U.S. its once-potential blockbuster blood thinner Zontivity and will slash 148 jobs designated to sell and promote the product after bleeding risks narrowed its hopes for expanding its treatment options, and competition from other drugs flooded the market. Zontivity, known chemically as vorapaxar, was obtained by Merck when it bought out Schering-Plough. It was a first-in-class drug designed to be an alternative to the blood clot treatment warfarin in stroke patients. Analysts predicted the drug could bring in annual sales of as much as $5 billion. But those hopes were dashed when, ... Read More

Eliquis safety label updated to warn there is no antidote in the event of an emergency

blood cells

The Food and Drug Administration (FDA) has approved an updated safety label for the blood thinner Eliquis to include a warning that a reversal agent is not currently available in the event of a bleeding emergency. Eliquis, whch is manufactured by Bristol-Myers Squibb and Pfizer, contains the active drug ingredient apixaban. It is in a new class of blood thinners known as Factor Xa inhibitors. Other drugs in this class include Pradaxa, Xarelto, and Savaysa. The medications are used to prevent strokes in patients with the common heart rhythm abnormality called atrial fibrillation. Eliquis is also used to treat deep ... Read More

Lawsuits allege Xarelto makers misled doctors, patients about risks

xarelto

Johnson & Johnson’s Janssen Pharmaceuticals and Bayer misled consumers when they marketed their blood thinner Xarelto as a superior alternative to the long-used warfarin, a generic drug that costs a mere fraction of Xarelto, plaintiffs suing the drug’s manufacturers claim. Patients taking Xarelto do not need to follow any dietary restrictions or have their blood monitored on a regular basis, which does make Xarelto more convenient than warfarin. But unlike warfarin, there is no antidote to reverse the bleeding effects of Xarelto in the event of a bleeding emergency. Xarelto is used to prevent strokes in patients with the common ... Read More

California judge allows Essure lawsuits to advance

Essure

A California judge has found that under state law, lawsuits filed by 14 women in 11 consolidated cases involving allegations that Bayer had failed to warn the Food and Drug Administration (FDA) about tens of thousands of complaints associated with its permanent birth control device Essure from 2008 to 2013, are not preempted by federal law and can advance. Bayer had argued that it was protected from personal injury lawsuits because the device had been approved by the FDA. Superior Court Judge Winifred Y. Smith disagreed. However, she did side with Bayer in one area, saying that claims made by ... Read More

Court’s ruling could open door for more Essure lawsuits

Essure

A California state court ruling clearing the way for 11 lawsuits over alleged injuries caused by Bayer’s permanent birth control device Essure could have major implications for manufacturers of medical devices who, like Bayer, had received federal protection from personal injury claims. Bayer claimed that the cases should be thrown out on three separate grounds, but for each, Judge Winifred Y. Smith of the Superior Court in Alameda County denied Bayer’s argument. One of Bayer’s arguments was that the device was protected under federal preemption law, which does not allow plaintiffs to sue makers of medical devices that were approved ... Read More

Essure birth control lawsuits mount against Bayer

Essure

Dozens of women have are suing Bayer and its related companies over injuries they say were caused by the companies’ “defective” permanent birth control Essure. Christy Rios, Kelly Straley, Crystal McManamon, and Michelle McKay are just some of the women who filed a lawsuit on July 25 in Madison County Circuit Court against Bayer Corp., Bayer Healthcare LLC, Bayer Essure Inc., and Bayer Healthcare Pharmaceuticals. They allege the companies are guilty of breach of duty by manufacturing actual Essure contraceptives that are different from those detailed in federal specifications. The women say that as a result of using Essure they ... Read More

Bayer ordered to collect data on Essure side effects

Essure

The Food and Drug Administration (FDA) is ordering Bayer to conduct a study aimed at providing insight into the “real world” risks associated with its controversial permanent birth control device Essure. Essure was approved in 2002 and remains the only non-surgical birth control method on the market. It consists of two nickel alloy coils that are inserted into the fallopian tubes. Over the course of about three months, scar tissue builds up around the coils and creates a barrier that prevents pregnancy by blocking the sperm’s path to the egg. Essure has been linked to tens of thousands of complications ... Read More